Research Article
MicroRNA Expression Profiling in PBMCs: A Potential Diagnostic Biomarker of Chronic Hepatitis C
Table 4
The association of the targets miRNAs expression levels and clinical factors (such as ALT, AST, and liver fibrosis) of the CHC patients.
| Parameters | miR-193b | miR-199a-3p | miR-122 | miR-16 | miR-214 | miR-222 | miR-324-3p |
| ALT | | | | | | | | <40 U/L | 0.169 ± 0.838 | 777.105 ± 2178.070 | 0.003 ± 0.010 | 21.762 ± 69.405 | 18.220 ± 65.577 | 0.425 ± 0.954 | 7.771 ± 39.245 | ≧40 U/L | 0.214 ± 1.464 | 1113.280 ± 497.265 | 0.001 ± 0.002 | 212.344 ± 504.989 | 54.410 ± 200.481 | 3.425 ± 11.770 | 26.781 ± 67.231 | value | 0.001 | 0.009 | <0.0001 | <0.0001 | 0.235 | <0.0001 | 0.001 | AST | | | | | | | | <40 U/L | 0.027 ± 0.005 | 426.223 ± 1115.870 | 0.003 ± 0.012 | 13.217 ± 40.283 | 17.412 ± 64.851 | 0.496 ± 1.135 | 11.157 ± 48.112 | ≧40 U/L | 0.174 ± 1.297 | 882.580 ± 436.044 | 0.001 ± 0.003 | 168.314 ± 445.087 | 45.757 ± 177.139 | 2.631 ± 10.244 | 20.214 ± 58.935 | value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.760 | <0.0001 | 0.001 | Liver cirrhosis | | | | | | | | No | 0.228 ± 1.410 | 964.452 ± 454.544 | 0.017 ± 0.122 | 197.502 ± 490.549 | 150.749 ± 891.345 | 2.529 ± 5.821 | 45.846 ± 209.718 | Yes | 0.012 ± 0.029 | 1340.147 ± 440.160 | 0.001 ± 0.003 | 109.524 ± 243.190 | 40.417 ± 79.656 | 6.452 ± 19.406 | 34.221 ± 86.321 | value | 0.221 | 0.800 | 0.866 | 0.996 | 0.054 | 0.584 | 0.508 |
|
|
AST: aspartate aminotransferase; ALT: alanine aminotransferase.
|